Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC

INTRODUCTION: Plasma-based circulating tumor DNA (ctDNA) is an established biomarker for molecular profiling with emerging applications in disease monitoring in multiple tumor types, including non-small cell lung cancer (NSCLC). However, determinants of ctDNA shedding and correlation with tumor burd...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Thorac Oncol
Κύριοι συγγραφείς: Lam, Vincent K., Zhang, Jianjun, Wu, Carol C., Tran, Hai T., Li, Lerong, Diao, Lixia, Wang, Jing, Rinsurongkawong, Waree, Raymond, Victoria M., Lanman, Richard B., Lewis, Jeff, Roarty, Emily B., Roth, Jack, Swisher, Stephen, Lee, J. Jack, Gibbons, Don L., Papadimitrakopoulou, Vassiliki A., Heymach, John V.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012216/
https://ncbi.nlm.nih.gov/pubmed/33388476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2020.12.011
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια